OncoSnap BRCATM is a pioneering NGS-based tumor tissue profiling test which screens for somatic mutations of BRCA1 and BRCA2 genes in solid tumor tissues. This test is useful for assessing patients who are diagnosed with breast cancer, ovarian cancer and prostate cancer on whether they could be benefited from selected PARP inhibitor treatments.
Sample types:FFPE Block or 5μm unstained FFPE slides mounted on slides
Turnaround time: 14working days upon sample arrival
Who are suitable?